52315

Cystourethroscopy, with resection of tumor(s), bladder, single or multiple, non-muscle invasive

CPT code 52315 describes a cystourethroscopic procedure involving the resection of one or more non-muscle invasive tumors located within the bladder. This procedure, commonly known as a Transurethral Resection of Bladder Tumor (TURBT), is both diagnostic and therapeutic. During the procedure, a cystoscope—a thin, lighted tube with a camera—is inserted through the urethra into the bladder. The surgeon visualizes the bladder lining for any suspicious lesions, which may have been previously identified through imaging or presented with symptoms like hematuria. Once a tumor is identified, a specialized instrument with an electrical loop is passed through the cystoscope to carefully resect, or cut away, the tumor tissue. The goal is to remove all visible tumor tissue down to the underlying bladder muscle layer, ensuring complete removal of the non-muscle invasive components. The resected tissue is then retrieved for histopathological examination, which is crucial for determining the exact type and grade of bladder cancer, as well as confirming the depth of invasion. Hemostasis is achieved using electrocautery to control any bleeding. This procedure is fundamental in the management of non-muscle invasive bladder cancer, allowing for accurate staging, removal of cancerous tissue, and guiding subsequent treatment decisions such as adjuvant intravesical therapy.

Clinical Indications

  • Gross or microscopic hematuria of unknown etiology, especially with a suspicion of bladder neoplasm.
  • Detection of suspicious lesions or masses within the bladder on imaging studies (e.g., ultrasound, CT scan, MRI).
  • Surveillance for recurrence in patients with a history of non-muscle invasive bladder cancer.
  • Presence of abnormal urine cytology suggestive of urothelial carcinoma.
  • Symptoms such as dysuria, urgency, or frequency, especially if persistent and unresponsive to conservative management, and associated with a bladder lesion.
  • Monitoring response to intravesical therapies for bladder cancer.
  • Biopsy of bladder lesions to establish a definitive diagnosis of bladder cancer.

Procedure Steps

  1. Patient positioned in dorsal lithotomy under general or regional anesthesia.
  2. Sterile preparation and draping of the perineum.
  3. Cystoscope insertion: The cystoscope is carefully inserted through the urethra into the bladder.
  4. Bladder visualization and irrigation: The bladder is distended with sterile irrigating solution (e.g., saline) to allow clear visualization of the entire bladder mucosa.
  5. Tumor identification: Systematic inspection of the bladder walls, dome, trigone, and ureteral orifices to identify all suspicious lesions or tumors.
  6. Resection of tumor(s): A resectoscope with an electrosurgical loop is advanced through the cystoscope. The tumor is resected layer by layer, starting from the periphery and moving towards the base, ensuring adequate margins and resection down to the muscle layer without perforation.
  7. Fulguration of tumor base: The tumor base and surrounding areas are fulgurated with electrocautery to destroy any remaining microscopic tumor cells and achieve hemostasis.
  8. Collection of specimens: Resected tissue fragments are collected using an evacuator (e.g., Ellik or Toomey syringe) for histopathological analysis.
  9. Hemostasis: Thorough inspection for bleeding and additional fulguration as needed.
  10. Removal of instruments: The cystoscope and resectoscope are carefully withdrawn.
  11. Post-procedure care: A Foley catheter may be inserted temporarily for continuous bladder irrigation or drainage, depending on the extent of resection and hematuria.

Coding Guidelines

  • Code 52315 is used for transurethral resection of non-muscle invasive bladder tumors, whether single or multiple.
  • The inherent diagnostic cystoscopy is included in CPT code 52315 and should not be billed separately.
  • Documentation must clearly state that the tumor(s) were non-muscle invasive and provide details on the size, number, and location of the resected lesions.
  • If the resection involves a tumor that invades the muscle layer, a different CPT code (e.g., 52240 for extensive resection) may be more appropriate, depending on the extent and complexity.
  • Do not report 52315 in conjunction with other cystourethroscopy codes for diagnostic purposes (e.g., 52000, 52005) when performed during the same encounter.
  • If a tumor is simply biopsied without full resection, a different code such as 52204 (Cystourethroscopy, with biopsy(s)) would be used.
  • For repeat TURBT procedures, append modifier 78 (Unplanned Return to the Operating/Procedure Room by the Same Physician or Other Qualified Health Care Professional Following Initial Procedure for a Related Procedure During the Postoperative Period) or modifier 58 (Staged or Related Procedure or Service by the Same Physician or Other Qualified Health Care Professional During the Postoperative Period) as appropriate, depending on the clinical scenario.

Associated ICD-10 Codes